CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net Income (Loss)	$ (45,525)	$ (26,912)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	650	586
Provision for expected credit losses	0	44
Stock-based compensation expense	7,603	2,856
Provision for excess and obsolete inventory	189	(91)
Provision for net realizable value of inventory	158
Change in fair value of warrant liabilities	12,450	7,809
Accretion of discount on short-term investments	(1,709)	(1,667)
Accretion of discount on long-term investments	(21)
Amortization of operating lease right-of-use asset	607	553
Loss on disposal of property and equipment		8
Changes in operating assets and liabilities:
Accounts receivable	601	(4,556)
Inventories	(4,350)	(6,301)
Prepaid expenses and other current assets	(3,605)	(937)
Other long-term assets	6	5
Accounts payable	471	1,470
Accrued expenses and other current liabilities	(2,550)	2,069
Other long-term liabilities	1,011
Operating lease liability	(567)	(454)
Deferred revenue	1,012	1,137
Net cash used in operating activities	(33,569)	(24,381)
Cash flows from investing activities:
Purchases of short-term investments	(190,768)	(20,193)
Purchases of long-term investments	(31,069)
Proceeds from maturities and redemptions of short-term investments	51,000	32,000
Proceeds on disposal of property and equipment		50
Purchases of property and equipment	(2,112)	(913)
Net cash (used in) provided by investing activities	(172,949)	10,944
Cash flows from financing activities:
Payments of deferred offering costs		(119)
Proceeds from the issuance of common stock, net of underwriting discounts, commissions and issuance costs	195,430
Proceeds from the issuance of common stock from private placement, net of issuance costs	15,591
Proceeds from stock option exercises	140	6
Proceeds from common stock warrants exercise		12
Net cash provided by financing activities	211,161	(101)
Net increase (decrease) in cash, cash equivalents and restricted cash	4,643	(13,538)
Cash, cash equivalents and restricted cash at beginning of period	30,532	26,667
Cash, cash equivalents and restricted cash at end of period	35,175	13,129
Supplemental disclosure of non-cash investing and financing information:
Purchases of property and equipment included in accounts payable	101	956
Purchases of property and equipment in accrued expenses and other current liabilities	127
Deferred offering costs included in accrued expenses		40
Unrealized gain (loss) on short-term investments	(25)	(158)
Unrealized gain (loss) on long-term investments	(59)
Reclassification of long-term investments to short-term investments	79,838
Conversion of convertible preferred stock upon IPO	321,373
Conversion of warrants net exercise upon IPO	57,348
Reclassification of deferred offering costs to equity upon IPO	5,051
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents	35,075	13,029
Restricted cash	100	100
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	$ 35,175	$ 13,129